Evidence map›Paper›PMID 41182007›Full record

ArticleJournal of the American Heart Association2025

Inflammation and Cognitive Decline: A Population-Based Cohort Study Among Aging Adults With Atrial Fibrillation.

Danielle Marion, Zhe Li, Austyn Roseborough, Shawn N Whitehead, Ellen E Freeman, David H Birnie, Fanny M Elahi, Vladimir Hachinski, Mary Cushman, Jodi D Edwards

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Danielle MarionSchool of Epidemiology and Public Health University of Ottawa Ottawa ON Canada.
Zhe LiUniversity of Ottawa Heart Institute Ottawa ON Canada.ORCID 0000-0001-7856-2431
Austyn RoseboroughDepartment of Anatomy & Cell Biology University of Western Ontario London ON Canada.ORCID 0000-0001-7823-8199
Shawn N WhiteheadDepartment of Anatomy & Cell Biology University of Western Ontario London ON Canada.ORCID 0000-0003-4728-8067
Ellen E FreemanSchool of Epidemiology and Public Health University of Ottawa Ottawa ON Canada.ORCID 0000-0002-1403-8427
David H BirnieUniversity of Ottawa Heart Institute Ottawa ON Canada.ORCID 0000-0001-6495-1428
Fanny M ElahiDepartments of Neurology and Neuroscience Icahn School of Medicine at Mount Sinai New York NY USA.ORCID 0000-0003-4663-4992
Vladimir HachinskiDepartment of Clinical Neurological Sciences, London Health Sciences Centre Western University London ON Canada.ORCID 0000-0002-0487-734X
Mary CushmanDepartment of Medicine Larner College of Medicine at the University of Vermont Burlington VT USA.ORCID 0000-0002-7871-6143
Jodi D EdwardsSchool of Epidemiology and Public Health University of Ottawa Ottawa ON Canada.ORCID 0000-0002-9275-4787

Funding

Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Fanny M Elahi · 2020 to 2026
$31.0M
NIA NIH HHS P30 AG066514
6 · The paper itself

Abstract

backgroundDespite associations between atrial fibrillation (AF) and cognitive decline independent of stroke, pathways underlying this relationship remain unclear. Inflammatory markers, such as CRP (C-reactive protein), are associated with blood-brain barrier (BBB) permeability, potentially leading to neuroinflammation and neurodegeneration. We estimated associations of CRP with cognitive impairment and death in aging adults with AF.

methodsAdults aged ≥45 years with prevalent AF and no cognitive impairment were identified from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) cohort (N=30 239). Plasma CRP was measured at baseline and cognitive status measured annually using the Six-Item Screener. Competing risks Cox proportional hazards regression was used to estimate cause-specific hazard for cognitive impairment (Six-Item Screener score ≤3). Cognitive trajectories were identified using latent class growth models and adjusted binomial logistic regression used to estimate associations between CRP and cognitive trajectories, with interactions by sex.

resultsAmong 2109 participants, 285 developed cognitive impairment and 786 died over a median 9-year follow-up. A doubling of baseline CRP levels was associated with increased death (hazard ratio [HR], 1.13 [95% CI, 1.08-1.19]) but not incident cognitive impairment (HR, 0.98 [95% CI, 0.91-1.04]). Latent class analyses identified 2 unique cognitive trajectories: 91% had a stable trajectory, while 9% showed progressive decline. Sex-specific models showed a 9% increased odds of progressive cognitive decline in men (odds ratio, 1.09 [95% CI, 1.01-1.17]) but not women (odds ratio, 1.04 [95% CI, 0.97-1.12]).

conclusionsHigher CRP was associated with cognitive impairment in aging men with AF, highlighting inflammation-mediated blood-brain barrier dysfunction as a potential pathway linking AF to cognitive decline.

Indexed as

AgingAtrial FibrillationCognitionCognitive DysfunctionC-Reactive ProteinInflammationAgedBiomarkersFemaleHumansMaleMiddle AgedRisk AssessmentRisk FactorsUnited StatesBiomarkersC-Reactive Proteinatrial fibrillationblood–brain barrier permeabilitycognitive decline

Identifiers

PMID41182007
PMCPMC12684798

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.